HWP
RMD icon

Highline Wealth Partners’s ResMed RMD Stock Holding History

Highline Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46K Buy
28
+20
+250% +$4.14K ﹤0.01% 836
2026
Q1 		$1.8K Sell
8
-1
-11% -$249 ﹤0.01% 1080
2025
Q4 		$2.17K Sell
9
-1
-10% -$256 ﹤0.01% 835
2025
Q3 		$2.74K Buy
10
+1
+11% +$273 ﹤0.01% 783
2025
Q2 		$2.32K Buy
9
+3
+50% +$716 ﹤0.01% 612
2025
Q1 		$1.34K Buy
+6
New +$1.4K ﹤0.01% 696
2024
Q4 		– Sell
-71
Closed -$17.3K – 648
2024
Q3 		$17.3K Buy
+71
New +$15.9K 0.01% 199

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Highline Wealth Partners's RMD Position: Q2 2026 in Review

Highline Wealth Partners increased its ResMed (RMD) stake by 250% in Q2 2026, buying an estimated $4.14K and bringing the position to 28 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Highline Wealth Partners first reported a position in RMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $17.3K in Q3 2024. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Highline Wealth Partners held 28 shares of ResMed worth $5.46K as of Q2 2026.
  • Highline Wealth Partners bought 20 ResMed shares in Q2 2026, an estimated $4.14K.
  • ResMed made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #836 holding.
  • Highline Wealth Partners first reported a position in ResMed in Q3 2024 and has held it in 7 quarters since.
  • Highline Wealth Partners's ResMed position peaked at $17.3K in Q3 2024.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.